Time to recovery among tuberculosis patients receiving anti-Koch’s drug in Ibadan, Oyo State, Nigeria

This study showed a significant recovery after the use of anti-Kochs drugs. The recovery time of the participants was 61 days, which indicated that anti-Kochs drug is very effective for TB treatment. To increase adherence, it is suggested that the policy should be changed from the required time of 6 months (180 days) to 2 months (61 days), since the drugs require them to maintain a good diet during the time of taking the drugs. This finding is useful to the National TB Control Program and the hospital authorities.

Authors

Institutions

Publication Details

Journal
BMC Infectious Diseases
Published
2025-10-28
DOI
https://doi.org/10.1186/s12879-025-11873-8
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Time to recovery among tuberculosis patients receiving anti-Koch’s drug in Ibadan, Oyo State, Nigeria

Yusuff Akinkunmi Olasunkanmi, Ayo Stephen Adebowale, Adeniyi Francis Fagbamigbe, Rotimi Felix Afolabi et al.
BMC Infectious Diseases
Tuberculosis Research and Epidemiology
article

Time to recovery among tuberculosis patients receiving anti-Koch’s drug in Ibadan, Oyo State, Nigeria

Yusuff Akinkunmi Olasunkanmi, Ayo Stephen Adebowale, Adeniyi Francis Fagbamigbe, Rotimi Felix Afolabi, Olowolafe Tubosun Alex
article en

Abstract

This study showed a significant recovery after the use of anti-Kochs drugs. The recovery time of the participants was 61 days, which indicated that anti-Kochs drug is very effective for TB treatment. To increase adherence, it is suggested that the policy should be changed from the required time of 6 months (180 days) to 2 months (61 days), since the drugs require them to maintain a good diet during the time of taking the drugs. This finding is useful to the National TB Control Program and the hospital authorities.

BMC Infectious DiseasesVol. 25(1)
University of Ibadan (NG), Institute of Human Virology (NG), Lead City University (NG)
Openalex Percentile: Top 63%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Time to recovery among tuberculosis patients receiving anti-Koch’s drug in Ibadan, Oyo State, Nigeria — Yusuff Akinkunmi Olasunkanmi, Ayo Stephen Adebowale, et al. · BMC Infectious Diseases (2025) | TGRS Research Map | TGRS